Company Filing History:
Years Active: 2015-2020
Title: Kevin Kwei: Innovator in Tumor Treatment and Microvesicle Isolation
Introduction
Kevin Kwei is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the fields of tumor treatment and microvesicle isolation. With a total of 2 patents, Kwei's work is at the forefront of medical innovation.
Latest Patents
Kwei's latest patents include methods for using immunoglobulin expression levels as biomarkers for proteasome inhibitor response. These methods provide innovative approaches to treating tumors in subjects by measuring the levels of specific genes, such as FCGR2B. Additionally, he has developed methods for microvesicle isolation, which focus on purifying and concentrating microvesicles produced by mammalian cells. This invention is crucial for creating blood serum or plasma that is free from detectable microvesicles, enhancing experimental systems that require microvesicle-depleted media.
Career Highlights
Throughout his career, Kevin Kwei has worked with prominent companies such as System Biosciences, LLC and Onyx Therapeutics, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in his field.
Collaborations
Kwei has collaborated with talented individuals, including Travis John Antes and Fangting Wu. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of medical technologies.
Conclusion
Kevin Kwei's contributions to the fields of tumor treatment and microvesicle isolation highlight his role as a leading inventor. His innovative patents and collaborations continue to push the boundaries of medical research and technology.